<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Novo Nordisk | R/Pharma</title>
    <link>/tag/novo-nordisk/</link>
      <atom:link href="/tag/novo-nordisk/index.xml" rel="self" type="application/rss+xml" />
    <description>Novo Nordisk</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â© R/Pharma 2022</copyright><lastBuildDate>Thu, 10 Nov 2022 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/media/logo_hu7da996d8ce7178f65929875a2132de7e_457633_300x300_fit_lanczos_2.png</url>
      <title>Novo Nordisk</title>
      <link>/tag/novo-nordisk/</link>
    </image>
    
    <item>
      <title>Co-existence of R and SAS for multiple imputation in Novo Nordisk</title>
      <link>/publication/rinpharma_286/</link>
      <pubDate>Thu, 10 Nov 2022 00:00:00 +0000</pubDate>
      <guid>/publication/rinpharma_286/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Automatic generation of PowerPoint presentation for communication of clinical trial results</title>
      <link>/publication/rinpharma_243/</link>
      <pubDate>Thu, 04 Nov 2021 00:00:00 +0000</pubDate>
      <guid>/publication/rinpharma_243/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
